Banks Benefit From ...
Health Care: Drugs
Geron Corporation (GERN: NASDAQ)
$2.05 -0.02 | -0.97%
02/09/12 - 04:00 PM ET
463.18K / 1.48M
Vol / Avg. Vol:2.09 / 2.07
Open / Prev. Close:2.04 - 2.09
Today's Range:1.35 - 5.24
52 Wk Range:39.86%
Performance YTD:TheStreet Rating:
Portfolios with GERN
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- UserMy Portfolio
- ContributorStem Cell Stocks
- Usermitetwo Portfolio 1
- Usergellis1360 Portfolio 1
- UserStocks I would like to buy ...
- UserPART 6 JPMorgan 28th Annual...
- UserRet2009
- UserDCL-Trader Portfolio 1
- UserNumina Stocks
Latest GERN Headlines from TheStreet
- More Biotech Lessons Learned From JPM 2012 01.13.12 | 06:01 am
- The 5 Dumbest Things on Wall Street: Nov. 18
11.18.11 | 05:11 am - Geron Stock Hits New 52-Week Low (GERN) 11.17.11 | 11:11 am
- Business Highlights 11.15.11 | 06:11 pm
- Geron's Stem Cell Bust Leaves Investors Holding the Bag 11.15.11 | 09:11 am
- Geron Stock Gaps Down On Today's Open (GERN) 11.15.11 | 08:11 am
- 5 Stocks With Big Insider Buying 10.12.11 | 01:10 pm
- Geron Stock Hits New 52-Week Low (GERN) 10.03.11 | 03:10 pm
- Geron Stock Hits New 52-Week Low (GERN) 09.21.11 | 04:09 pm
- Geron Stock Hits New 52-Week Low (GERN) 08.19.11 | 02:08 pm
Press Releases for GERN
- Geron Initiates Phase 2 Trial Of GRN1005 In Brain Metastases From Breast Cancer - Business Wire 12.12.11 | 07:12 am
- Geron Presents Final Phase 1 Clinical Data On GRN1005 At AACR-NCI-EORTC - Business Wire 11.15.11 | 07:11 am
- Geron To Focus On Its Novel Cancer Programs - Business Wire 11.14.11 | 04:11 pm
- Geron Corporation Reports 2011 Third Quarter Financial Results And Events - Business Wire 11.03.11 | 04:11 pm
- Geron Announces Conference Call To Discuss Third Quarter Financial Results And Highlights - Business Wire 10.25.11 | 04:10 pm
- Geron Announces Presentation At ECTRIMS/ACTRIMS - Business Wire 10.25.11 | 07:10 am
- Geron Presents Clinical Data Update From GRNOPC1 Spinal Cord Injury Trial - Business Wire 10.20.11 | 07:10 am
- Geron Corporation Appoints John A. Scarlett As Chief Executive Officer And Director - Business Wire 09.29.11 | 05:09 pm
- Geron To Webcast Presentations At Upcoming Investor Conferences - Business Wire 09.12.11 | 07:09 am
- Geron Corporation Reports 2011 Second Quarter Financial Results And Events - Business Wire 07.28.11 | 04:07 pm
Partner Headlines for GERN
- Geron Corporation Appoints Graham Cooper as Chief Financial Officer - Benzinga 01.05.12 | 04:01 pm
- Osiris Shows No Reason To Invest In Stem Cell Ideas - Seeking Alpha 01.05.12 | 08:01 am
- Noteworthy Insider Buys In The Healthcare Sector Last Week - Seeking Alpha 11.29.11 | 08:11 am
- 10 Stocks To Watch This Week - Seeking Alpha 10.16.11 | 09:10 am
- Healthcare Stocks To Watch This Week - Seeking Alpha 10.12.11 | 08:10 am
- Due Diligence And Speculative Biotech Investing - Seeking Alpha 09.27.11 | 08:09 am
- This Week's Healthcare Stock Watch - Seeking Alpha 09.20.11 | 09:09 am
- Gambling With Speculative Healthcare Stocks - Seeking Alpha 09.06.11 | 09:09 am
- Earnings Report Card, Regenerative Medicine Universe Edition - Seeking Alpha 08.11.11 | 09:08 am
- Analyst Interview - International Stem Cell - Analyst Blog - Zacks 07.27.11 | 06:07 am
